Researchers sought to examine the effect of the 2018 changes to the US heart transplant allocation system on waitlist and posttransplant mortality in patients with LVADs.
Heartwire from Medscape, March 27, 2017 Optimism, Mixed Results for New-Gen LVADs vs Mainstay HeartMate 2 Differently designed ... 2017 AHA MOMENTUM 3: Fewer Reoperations With HeartMate 3 at ...
Some results have been hidden because they may be inaccessible to you